EURETINA Congress

EURETINA: 2020

Efficacy and Duration in AMD Therapeutic Trials

Show Description +

Jordi Monés, MD, PhD, discusses novel therapeutic approaches for neovascular AMD. Dr. Monés provides the data on various drugs in phase 1, 2, and 3 trials which are showing promise in improving efficacy as well as duration in AMD treatments.

Posted: 10/16/2020

Keywords:

Age-Related Macular Degeneration (AMD)

Up Next

Home-Based OCT and AMD

Anat Loewenstein, MD

OCS-01 in Phase 2: Topical Treatment for DME

Ramin Tadayoni, MD, PhD

Retinal Blood Flow in Diabetic Retinopathy

Deep Learning in AMD

Srinivas R. Sadda, MD

RGX-314 for Wet AMD

Robert Avery MD, PhD

Back to All Videos

Efficacy and Duration in AMD Therapeutic Trials

Jordi Monés, MD, PhD, discusses novel therapeutic approaches for neovascular AMD. Dr. Monés provides the data on various drugs in phase 1, 2, and 3 trials which are showing promise in improving efficacy as well as duration in AMD treatments.

Posted: 10/16/2020

Keywords:

Age-Related Macular Degeneration (AMD)